Dr. Perkins obtained his MD and Internal Medicine Residency training at the University of Toronto and his Endocrinology subspecialty training at Harvard University and the Joslin Diabetes Center. He completed his Masters of Public Health in Epidemiology at the Harvard School of Public Health. Dr. Perkins joined the Leadership Sinai Centre for Diabetes at Mount Sinai Hospital in 2013. He is a Professor and Clinician-Scientist at the University of Toronto and his research interests include the identification of valid early phenotypes for diabetic nephropathy and neuropathy as well as technologies in diabetes care including the use of insulin pumps and continuous glucose monitoring in clinical trials and clinical practice.
Dr. Cherney is a member of the Banting and Best Diabetes Centre at the University of Toronto where he is an Assistant Professor and Clinician-Scientist. His main research interests in type 1 diabetes include the physiology of renal hyperfiltration in diabetic nephropathy and functional gene polymorphisms in humans.
Our research team, responsibly social distancing during COVID. (left to right: Dr. Marcelo Falappa, Krista Lamb, NP Nancy Cardinez, Dr. Bruce Perkins, Erik Lovblom, Devrim Eldelekli, Daniel Scar, Dr. Evan Lewis. Not pictured here: Dr. Andrej Orszag)
Dr. Bril graduated with her MD from the University of Toronto. She joined the University Health Network in 2003. She is the Director of the Division of Neurology at the UHN. She is a Professor of Medicine at the University of Toronto and her clinical and research interests include Diabetic Neuropathy, Myasthenia Gravis, and Inflammatory Demyelinating Polyneuropathies.
Dr. Brent graduated with his MD from McMaster University in 1983. He completed an internship in Internal Medicine at the University of Toronto before completing the Ophthalmology Residency Program in Toronto in 1987. Dr. Brent joined the department of Ophthalmology at the Toronto Western Hospital, University Health Network in 2005. He is an Assistant Professor at the University of Toronto and his main clinical and research interests are in Macular Degeneration and Diabetic Retinopathy.
Dr. Keenan is a research associate at the Joslin Diabetes Center and a co-principal investigator for the Joslin 50-Year Medalist Study, part of the Joslin Medalist Program.
Dr. Weisman is a clinician-scientist and endocrinologist at the Leadership Sinai Centre for Diabetes.
As part of her research program in type 1 diabetes she is leading the development of a new province-wide database. This database will drive new research analysis by her team and others for people living with type 1 diabetes.
Dr. Weisman is also leading studies of the real-world feasibility of recommended glycemic targets in type 1 diabetes, and is examining the impact of government-funded insulin pump programs on the uptake of this technology in people with type 1 diabetes.
Dr. Lovshin directs the Diabetes Complications Research Laboratory (DCRL), a new clinical investigation unit in the division of Endocrinology & Metabolism at the Sunnybrook Health Sciences Centre. Dr. Lovshin’s research interests are focused on understanding the mechanisms of diabetes complications, with a specific focus on improving vascular health and reducing vascular complications and events associated with metabolic diseases including Type 1 and Type 2, and Obesity.
Through clinical investigative techniques which span epidemiology to translational mechanistic clinical studies, Dr. Lovshin is interested in determining how changes in the cardio-renal axis contribute to heart and kidney complications in diabetes. Dr. Lovshin is also interested in changes in the diabetic retina and central nervous system and in determining how these pathophysiological changes contribute to complications in the eye and brain.
The JDRF, formerly known as the Juvenile Diabetes Research Foundation, is a global leader in the search for an end to type 1 diabetes through research funding and advocacy. They are committed to improving the lives of every person with type 1 diabetes and to curing the disease. The JDRF supports research projects in three basic areas: cure, treatment, and prevention.
For more information visit: www.jdrf.ca
Located in the heart of the discovery district in Toronto, Mount Sinai Hospital is a state-of-the-art, 472-bed patient care, teaching, and research hospital. The Sinai Health System focuses on three broad organizational goals:
For more information visit: www.mountsinai.on.ca
The University Health Network (UHN) is a major landmark in Canada’s healthcare system and a teaching hospital of the University of Toronto. Spanning across all major disciplines, the UHN includes Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Center, and Toronto Rehab. On a mission for exemplary patient care, research, and education, the UHN vision is to achieve global impact.
For more information visit: www.uhn.ca
The Joslin Diabetes Center is a teaching and research affiliate of Harvard Medical School at Harvard University. They are a one-of-a-kind institution on the front lines of the world epidemic of diabetes and are leading the battle to conquer diabetes in all of its forms through cutting-edge research and innovative approaches to clinical care and education. Their vision is a world free of diabetes and its complications and their mission is to prevent, treat, and cure diabetes.
For more information visit: www.joslin.org